Physician profile
David Wayne Hamula
NPI 1205450525
$1,861.87
in general payments reported to CMS, 2019-2025
10 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $370 · 2021: $407 · 2022: $501 · 2023: $42.25 · 2024: $196 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $351.39 | 2021-2022 | |
| American Orthodontics Corporation | $315.77 | 2023-2025 | Radiance, Empower-Ceramic, Master Series |
| Ormco Corporation | $288.70 | 2021-2022 | |
| Align Technology, INC. | $213.89 | 2020-2025 | Invisalign |
| Patterson Companies, INC. | $118.47 | 2022-2024 | |
| Envista Holdings Corporation | $74.83 | 2025 | Insignia |
| 3m Company | $54.24 | 2021 | |
| Gc America INC. | $46.50 | 2020-2023 | Initialloy |
| Solventum Corporation | $26.00 | 2025 | Clarity Aligners, 3m Unitek Mbt |
| Straumann USA LLC | $14.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hamula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.